Steve Toogood in 305 mile cycle challenge in aid of Prostate Cancer UK

City supporter Steve Toogood will shortly be undertaking a gruelling 305 mile cycle ride to raise money for Prostate Cancer UK, following the sad news that his father, and fellow long-term Romans fan, Merv Toogood has been diagnosed with the disease. Steve says:

Lots of you know that my Dad and long term City supporter, Merv Toogood, has been diagnosed with Prostate Cancer. This is sad news but I want to thank all of the City fans and staff who have so far wished Merv and our family all the very best in fighting this disease.

To raise money for Prostate Cancer UK, I have decided to take on an endurance challenge. I will be cycling 305 miles between 05th and 07th March. 305 miles is the distance between London Paddington and Penzance by rail. My journey will be broken down into 3 stages, which are as follows: 

Day 1 London Paddington – Castle Cary (115 miles)
Day 2 Castle Cary – Plymouth (110 miles)
Day 3 Plymouth – Penzance (80 miles) 

As a covid-limitation, I will be doing this on my exercise bike at home, but I will be replicating the route as close as possible including all of the climbs along the way.  The gradient profiles are on the link to our fundraising page which is below.

The fundraising total, at the time of writing, is close to £1,700 and JustGiving have confirmed that this challenge was in the top 5% of fundraising challenges for January 2021. 

Throughout the course of my training, I have spoken to so many people who have been impacted by Prostate Cancer. This means any money that you donate, should you wish, goes to help so many people and not just us at this time. Prostate Cancer UK is also the registered charity partner of the National League. 

Weblink: https://www.justgiving.com/fundraising/steven-toogood

Thanks again to everyone who has sent their best wishes and to those of you that have sponsored me. It is very much appreciated. And thank you in advance to those of you that will sponsor me after reading this message.